FutureFuel Second Quarter Net Income of
$0.8 Million
FutureFuel Corp. (NYSE:FF) (“FutureFuel”), a manufacturer of custom
and performance chemicals and biofuels, today announced financial
results for the second quarter and the six months ended June 30,
2017.
Second Quarter 2017 Financial
Highlights (all comparisons are with the second quarter of
2016)
- Revenues were $68.0 million, up 0.2% from $67.9 million
- Adjusted EBITDA was $2.1 million, down 84.6% from $13.6
million
- Net income decreased to $0.8 million, or $0.02 per diluted
share, from $14.2 million, or $0.33 per diluted share.
Six Month 2017 Financial
Highlights (all comparisons are with the first half of
2016)
- Revenues were $122.1 million, up 6.6% from $114.5 million
- EBITDA was $7.6 million, down 71.1% from $26.3 million
- Net income decreased to $4.2 million, or $0.10 per diluted
share, from $24.8 million, or $0.57 per diluted share.
“A solid performance in our Chemicals segment this
quarter was overshadowed by weak margins in our Biodiesel business.
This market will continue to be challenged until the future of the
Blenders’ Tax Credit becomes clear and the USITC concludes its
investigation into Biodiesel from Argentina and Indonesia.
FutureFuel is positioned to perform well in that market when these
issues are resolved,” said Tom McKinlay, Chief Operating Officer
for FutureFuel Chemical Company.
2017 Regular Cash Dividends
FutureFuel paid a normal quarterly dividend of
$0.06 per share in the second quarter of 2017. The remaining
quarterly dividends of $0.06 per share will be paid in September
and December.
Financial Overview and Key Operating
Metrics
Financial and operating metrics, which include
non-GAAP financial measures, include dollars in thousands, except
per share amounts:
FutureFuel Corp. |
Certain Financial and Operating
Metrics |
(Unaudited) |
|
|
Three months ended June 30, |
|
|
|
|
|
Dollar |
|
% |
|
|
2017 |
|
|
|
2016 |
|
Change |
|
Change |
Revenues |
$ |
68,048 |
|
|
$ |
67,879 |
|
$ |
169 |
|
|
0.2 |
% |
Income/(loss) from
operations |
$ |
(626 |
) |
|
$ |
5,376 |
|
$ |
(6,002 |
) |
|
(111.6 |
%) |
Net income |
$ |
834 |
|
|
$ |
14,224 |
|
$ |
(13,390 |
) |
|
(94.1 |
%) |
Earnings per common
share: |
|
|
|
|
|
|
|
Basic |
$ |
0.02 |
|
|
$ |
0.33 |
|
$ |
(0.31 |
) |
|
(93.9 |
%) |
Diluted |
$ |
0.02 |
|
|
$ |
0.33 |
|
$ |
(0.31 |
) |
|
(93.9 |
%) |
Capital expenditures
and intangibles (net of customer reimbursements and regulatory
grants) |
$ |
715 |
|
|
$ |
1,357 |
|
$ |
(642 |
) |
|
(47.3 |
%) |
Adjusted EBITDA |
$ |
2,079 |
|
|
$ |
13,581 |
|
$ |
(11,502 |
) |
|
(84.7 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended June 30, |
|
|
|
|
|
Dollar |
|
% |
|
|
2017 |
|
|
|
2016 |
|
Change |
|
Change |
Revenues |
$ |
122,159 |
|
|
$ |
114,514 |
|
$ |
7,645 |
|
|
6.7 |
% |
Income from
operations |
$ |
2,849 |
|
|
$ |
13,905 |
|
$ |
(11,056 |
) |
|
(79.5 |
%) |
Net income |
$ |
4,230 |
|
|
$ |
24,793 |
|
$ |
(20,563 |
) |
|
(82.9 |
%) |
Earnings per common
share: |
|
|
|
|
|
|
|
Basic |
$ |
0.10 |
|
|
$ |
0.57 |
|
$ |
(0.47 |
) |
|
(82.5 |
%) |
Diluted |
$ |
0.10 |
|
|
$ |
0.57 |
|
$ |
(0.47 |
) |
|
(82.5 |
%) |
Capital expenditures
and intangibles (net of customer reimbursements and regulatory
grants) |
$ |
1,557 |
|
|
$ |
2,135 |
|
$ |
(578 |
) |
|
(27.1 |
%) |
Adjusted EBITDA |
$ |
7,648 |
|
|
$ |
26,283 |
|
$ |
(18,635 |
) |
|
(70.9 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial and Business Summary
Consolidated sales revenue in the three and six
months ended June 30, 2017 increased $169 and $7,645 compared
to the three and six months ended June 30, 2016. This increase
primarily resulted from higher prices in the biofuel segment.
However, for the three months ended June 30, 2017, higher prices in
the biofuel segment were mostly offset by reduced biofuel sales
volumes driven in part by the expiration of the federal blenders’
tax credit (“BTC”). Also, partially offsetting the sales
revenue increase in the three months ended June 30, 2017 was a 5%
decline in chemical segment revenue.
Gross profit in the three and six months ended June
30, 2017 decreased $6,174 and $11,097, compared to the
three and six months ended June 30, 2016. In the biofuel
segment, this decrease largely resulted from the absence of the BTC
which expired on December 31, 2016 and from losses incurred on
common carrier pipelines. We also experienced a reduction in
chemical sales volume for the three months ended June 30, 2017 as
compared to the prior year period.
Another significant impact to the reduction in
gross profit in the three and six months ended June 30, 2017 as
compared to the prior year periods was the adjustment in the
carrying value of our inventory as determined utilizing the LIFO
method of inventory accounting. This adjustment reduced gross
profit $3,272 and $5,148 in the three and six months ended June 30,
2017 and decreased gross profit $3,319 in the three months ended
June 30, 2016 and increased gross profit $2,257 in the six months
ended June 30, 2016.
Partially offsetting these declines was the change
in the unrealized and realized activity in derivative
instruments. In the three and six months ended June 30, 2017,
the gain was $524 and $1,803, respectively, as compared to a loss
in the three and six months ended June 30, 2016 of $5,139 and
$6,178. In addition, the change in the lower of cost or
market adjustment in the three and six months ended June 30, 2017
was a benefit as compared to the prior year period. In the
three and six months ended June 30, 2017, the lower of cost or
market adjustment was $957 in comparison to $1,895 in the three and
six months ended June 30, 2016.
Net income for the three and six months ended
June 30, 2017 decreased $13,390 and $20,563, respectively, as
compared to the same periods in 2016. The decrease
resulted from the lack of the benefit of tax credits and
incentives in effect in the three and six months ended June
30, 2016 which was not in effect in the three and six months ended
June 30, 2017. Additionally, the adjustments in the carrying value
of our inventory as determined utilizing the LIFO method of
inventory accounting negatively impacted net income in the three
and six months ended June 30, 2017 and in comparison, negatively
impacted net income in the three months ended June 30, 2016 and
benefited net income in the six months ended June 30,
2016.
Capital Expenditures
Capital expenditures and intangibles were $1,686 in
the first six months of 2017, compared with $2,254 in the same
period in 2016. FutureFuel was reimbursed for a portion of these
expenditures by certain customers as summarized in the following
table.
|
Six months ended June 30, |
|
|
2017 |
|
|
|
2016 |
|
Cash paid for capital
expenditures and intangibles |
$ |
1,686 |
|
|
$ |
2,254 |
|
Cash received as
reimbursement of capital expenditures |
$ |
(129 |
) |
|
$ |
(119 |
) |
Cash paid, net of
reimbursement, for capital expenditures |
$ |
1,557 |
|
|
$ |
2,135 |
|
|
Cash and Cash Equivalents and Marketable
Securities
Cash and cash equivalents and marketable securities
totaled $231,738 as of June 30, 2017, compared with $305,418 as of
December 31, 2016. The majority of the decrease in cash in
the first six months of 2017 was attributed to a special cash
dividend of $100,188 that was paid on January 13, 2017.
About FutureFuel
FutureFuel is a leading manufacturer of diversified
chemical products, specialty chemical products, and biofuel
products. In its chemicals business, FutureFuel manufactures
specialty chemicals for specific customers (“custom chemicals”) as
well as multi-customer specialty chemicals (“performance
chemicals”). FutureFuel’s custom chemicals product portfolio
includes a bleach activator for a major detergent manufacturer,
proprietary herbicide and intermediates for major life sciences
companies, and chlorinated polyolefin adhesion promoters and
antioxidant precursors for a major chemical company. FutureFuel’s
performance chemicals product portfolio includes polymer (nylon)
modifiers and several small-volume specialty chemicals for diverse
applications. FutureFuel’s biofuels segment primarily produces and
sells biodiesel to its customers. Please visit
www.futurefuelcorporation.com for more information.
Forward-Looking Statements
This document contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements deal with FutureFuel’s current
plans, intentions, beliefs, and expectations, and
statements of future economic performance. Statements containing
such terms as “believe,” “do not believe,” “plan,” “expect,”
“intend,” “estimate,” “anticipate,” and other phrases of similar
meaning are considered to contain uncertainty and are
forward-looking statements. In addition, from time to time
FutureFuel or its representatives have made or will make
forward-looking statements orally or in writing. Furthermore, such
forward-looking statements may be included in various filings that
the company makes with United States Securities and Exchange
Commission (the “SEC”), in press releases, or in oral statements
made by or with the approval of one of FutureFuel’s authorized
executive officers.
These forward-looking statements are subject to
certain known and unknown risks and uncertainties, as
well as assumptions that could cause actual results to differ
materially from those reflected in these forward-looking
statements. Factors that might cause actual results to differ
include, but are not limited to, those set forth under the headings
“Risk Factors” and “Management’s Discussion and Analysis of
Financial Condition and Results of Operations” in FutureFuel’s Form
10-K Annual Report for the year ended December 31, 2016 and in its
future filings made with the SEC. An investor should not place
undue reliance on any forward-looking statements contained in this
document, which reflect FutureFuel management’s opinions only as of
their respective dates. Except as required by law, the company
undertakes no obligation to revise or publicly release the results
of any revisions to forward-looking statements. The risks and
uncertainties described in this document and in current and future
filings with the SEC are not the only ones faced by FutureFuel. New
factors emerge from time to time, and it is not possible for the
company to predict which will arise. There may be additional risks
not presently known to the company or that the company currently
believes are immaterial to its business. In addition, FutureFuel
cannot assess the impact of each factor on its business or the
extent to which any factor, or combination of factors, may cause
actual results to differ materially from those contained in any
forward-looking statements. If any such risks occur, FutureFuel’s
business, operating results, liquidity, and financial condition
could be materially affected in an adverse manner. An investor
should consult any additional disclosures FutureFuel has made or
will make in its reports to the SEC on Forms 10-K, 10-Q, and 8-K,
and any amendments thereto. All subsequent written and oral
forward-looking statements attributable to FutureFuel or persons
acting on its behalf are expressly qualified in their entirety by
the cautionary statements contained in this document.
Non-GAAP Financial Measures
In this press release, FutureFuel used adjusted
EBITDA as a key operating metric to measure both performance and
liquidity. Adjusted EBITDA is a non-GAAP financial measure.
Adjusted EBITDA is not a substitute for operating income, net
income, or cash flow from operating activities (each as determined
in accordance with GAAP), as a measure of performance or liquidity.
Adjusted EBITDA has limitations as an analytical tool, and should
not be considered in isolation or as a substitute for analysis of
results as reported under GAAP. FutureFuel defines adjusted EBITDA
as net income before interest, income taxes, depreciation, and
amortization expenses, excluding, when applicable, non-cash
share-based compensation expense, public offering expenses,
acquisition-related transaction costs, purchase accounting
adjustments, loss on disposal of property and equipment, gains or
losses on derivative instruments, other non-operating income or
expense. Information relating to adjusted EBITDA is provided so
that investors have the same data that management
employs in assessing the overall operation and liquidity of
FutureFuel’s business. FutureFuel’s calculation of adjusted EBITDA
may be different from similarly titled measures used by other
companies; therefore, the results of its calculation are not
necessarily comparable to the results of other companies.
Adjusted EBITDA allows FutureFuel’s chief operating
decision makers to assess the performance and liquidity of
FutureFuel’s business on a consolidated basis to assess the ability
of its operating segments to produce operating cash flow to fund
working capital needs, to fund capital expenditures, and to pay
dividends. In particular, FutureFuel management believes that
adjusted EBITDA permits a comparative assessment of FutureFuel’s
operating performance and liquidity, relative to a performance and
liquidity based on GAAP results, while isolating the effects of
depreciation and amortization, which may vary among its operating
segments without any correlation to their underlying operating
performance, and of non-cash stock-based compensation expense,
which is a non-cash expense that varies widely among similar
companies, and gains and losses on derivative instruments, whose
immediate recognition can cause net income to be volatile from
quarter to quarter due to the timing of the valuation change in the
derivative instruments relative to the sale of biofuel.
A table included in this earnings release
reconciles adjusted EBITDA with net income, the most directly
comparable GAAP performance financial measure, and a table
reconciles adjusted EBITDA with cash flows from operations, the
most directly comparable GAAP liquidity financial
measure.
FutureFuel Corp. |
Condensed Consolidated Balance
Sheets |
(Dollars in thousands) |
|
|
(Unaudited) |
|
|
|
June 30, 2017 |
|
December 31, 2016 |
Assets |
|
|
|
Cash and
cash equivalents |
$ |
111,010 |
|
$ |
199,272 |
Accounts
receivable, inclusive of the blenders' tax credit of $0 and $5,495
and |
|
|
|
|
|
net of
allowances for bad debt of $0 and $0, at June 30, |
|
|
|
|
|
2017 and
December 31, 2016, respectively |
|
21,704 |
|
|
24,744 |
Inventory |
|
36,889 |
|
|
52,093 |
Marketable securities |
|
120,728 |
|
|
106,146 |
Other
current assets |
|
17,872 |
|
|
23,027 |
Total
current assets |
|
308,203 |
|
|
405,282 |
Property,
plant and equipment, net |
|
113,868 |
|
|
118,152 |
Other
assets |
|
5,518 |
|
|
5,609 |
Total
noncurrent assets |
|
119,386 |
|
|
123,761 |
Total
Assets |
$ |
427,589 |
|
$ |
529,043 |
Liabilities and
Stockholders’ Equity |
|
|
|
Accounts
payable |
$ |
19,428 |
|
$ |
24,053 |
Dividends
payable |
|
5,250 |
|
|
110,688 |
Other
current liabilities |
|
11,067 |
|
|
9,308 |
Total
current liabilities |
|
35,745 |
|
|
144,049 |
Deferred
revenue – long-term |
|
14,289 |
|
|
16,792 |
Other
noncurrent liabilities |
|
35,812 |
|
|
35,389 |
Total
noncurrent liabilities |
|
50,101 |
|
|
52,181 |
Total liabilities |
|
85,846 |
|
|
196,230 |
Commitments and contingencies: |
|
|
|
Preferred
stock, $0.0001 par value, 5,000,000 shares authorized, none |
|
|
|
|
|
issued
and outstanding |
|
- |
|
|
- |
Common
stock, $0.0001 par value, 75,000,000 shares authorized, |
|
|
|
|
|
43,749,970 and 43,749,970, issued and outstanding as of June 30,
2017 |
|
|
|
|
|
and
December 31, 2016, respectively |
|
4 |
|
|
4 |
Accumulated other comprehensive income |
|
7,499 |
|
|
3,540 |
Additional paid in capital |
|
281,828 |
|
|
281,087 |
Retained
earnings |
|
52,412 |
|
|
48,182 |
Total
Stockholders’ Equity |
|
341,743 |
|
|
332,813 |
Total
Liabilities and Stockholders’ Equity |
$ |
427,589 |
|
$ |
529,043 |
FutureFuel Corp. |
Condensed Consolidated Statements of
Operations |
and Comprehensive Income |
(Dollars in thousands, except per share
amounts) |
(Unaudited) |
|
|
Three months ended June 30, |
|
Six months ended June 30, |
|
|
2017 |
|
|
|
2016 |
|
|
|
2017 |
|
|
|
2016 |
|
Revenue |
$ |
68,048 |
|
|
$ |
67,879 |
|
|
$ |
122,159 |
|
|
$ |
114,514 |
|
Cost of goods sold and
distribution |
|
66,250 |
|
|
|
59,907 |
|
|
|
114,231 |
|
|
|
95,489 |
|
Gross profit |
|
1,798 |
|
|
|
7,972 |
|
|
|
7,928 |
|
|
|
19,025 |
|
Selling, general, and
administrative expenses |
|
1,579 |
|
|
|
1,858 |
|
|
|
3,479 |
|
|
|
3,695 |
|
Research and
development expenses |
|
845 |
|
|
|
738 |
|
|
|
1,600 |
|
|
|
1,425 |
|
|
|
2,424 |
|
|
|
2,596 |
|
|
|
5,079 |
|
|
|
5,120 |
|
Income/(loss)
from operations |
|
(626 |
) |
|
|
5,376 |
|
|
|
2,849 |
|
|
|
13,905 |
|
Other income, net |
|
1,508 |
|
|
|
1,931 |
|
|
|
3,026 |
|
|
|
2,099 |
|
Income before income
taxes |
|
882 |
|
|
|
7,307 |
|
|
|
5,875 |
|
|
|
16,004 |
|
Provision/(benefit) for
income taxes |
|
48 |
|
|
|
(6,917 |
) |
|
|
1,645 |
|
|
|
(8,789 |
) |
Net income |
$ |
834 |
|
|
$ |
14,224 |
|
|
$ |
4,230 |
|
|
$ |
24,793 |
|
|
|
|
|
|
|
|
|
Earnings per common
share |
|
|
|
|
|
|
|
Basic |
$ |
0.02 |
|
|
$ |
0.33 |
|
|
$ |
0.10 |
|
|
$ |
0.57 |
|
Diluted |
$ |
0.02 |
|
|
$ |
0.33 |
|
|
$ |
0.10 |
|
|
$ |
0.57 |
|
Weighted average shares
outstanding |
|
|
|
|
|
|
|
Basic |
|
43,665,171 |
|
|
|
43,527,857 |
|
|
|
43,641,038 |
|
|
|
43,501,599 |
|
Diluted |
|
43,675,688 |
|
|
|
43,528,759 |
|
|
|
43,649,400 |
|
|
|
43,507,509 |
|
|
|
|
|
|
|
|
|
Comprehensive
Income |
|
|
|
|
|
|
|
Net income |
$ |
834 |
|
|
$ |
14,224 |
|
|
$ |
4,230 |
|
|
$ |
24,793 |
|
Other
comprehensive income from unrealized |
|
|
|
|
|
|
|
net gain
on available-for-sale securities |
|
3,210 |
|
|
|
1,349 |
|
|
|
6,096 |
|
|
|
2,027 |
|
Income
tax effect |
|
(1,126 |
) |
|
|
(472 |
) |
|
|
(2,137 |
) |
|
|
(710 |
) |
Total
unrealized gain, net of tax |
|
2,084 |
|
|
|
877 |
|
|
|
3,959 |
|
|
|
1,317 |
|
Comprehensive income |
$ |
2,918 |
|
|
$ |
15,101 |
|
|
$ |
8,189 |
|
|
$ |
26,110 |
|
FutureFuel Corp. |
Consolidated Statements of Cash
Flows |
For the Six Months Ended June 30, 2017 and
2016 |
(Dollars in thousands) |
(Unaudited) |
|
|
Six months ended June 30, |
|
|
2017 |
|
|
|
2016 |
|
Cash flows
provided by operating activities |
|
|
|
Net
income |
$ |
4,230 |
|
|
$ |
24,793 |
|
Adjustments to reconcile net income to net cash provided by
operating activities: |
|
|
|
Depreciation |
|
5,808 |
|
|
|
5,257 |
|
Amortization of deferred financing costs |
|
72 |
|
|
|
72 |
|
Benefit
for deferred income taxes |
|
(1,763 |
) |
|
|
(4,969 |
) |
Change in
fair value of derivative instruments |
|
318 |
|
|
|
4,869 |
|
Other
than temporary impairment of marketable securities |
|
177 |
|
|
|
1,879 |
|
Impairment of fixed assets |
|
9 |
|
|
|
178 |
|
Gain/(loss) on the sale of investments |
|
392 |
|
|
|
(1,474 |
) |
Stock
based compensation |
|
750 |
|
|
|
954 |
|
Losses on
disposals of fixed assets |
|
77 |
|
|
|
137 |
|
Noncash
interest expense |
|
13 |
|
|
|
22 |
|
Changes
in operating assets and liabilities: |
|
|
|
Accounts
receivable |
|
5,613 |
|
|
|
21,708 |
|
Accounts
receivable – related parties |
|
(2,573 |
) |
|
|
(23 |
) |
Inventory |
|
15,204 |
|
|
|
6,240 |
|
Income
tax receivable |
|
4,262 |
|
|
|
(2,818 |
) |
Prepaid
expenses |
|
626 |
|
|
|
589 |
|
Prepaid
expenses – related party |
|
(7 |
) |
|
|
- |
|
Accrued
interest on marketable securities |
|
(11 |
) |
|
|
(104 |
) |
Other
assets |
|
19 |
|
|
|
(321 |
) |
Accounts
payable |
|
(5,150 |
) |
|
|
(17,948 |
) |
Accounts
payable – related parties |
|
525 |
|
|
|
1,584 |
|
Accrued
expenses and other current liabilities |
|
1,370 |
|
|
|
2,470 |
|
Accrued
expenses and other current liabilities – related parties |
|
(142 |
) |
|
|
- |
|
Deferred
revenue |
|
(1,972 |
) |
|
|
2,933 |
|
Other
noncurrent liabilities |
|
112 |
|
|
|
- |
|
Net cash provided by operating activities |
|
27,959 |
|
|
|
46,028 |
|
Cash flows from
investing activities |
|
|
|
Collateralization of derivative instruments |
|
(34 |
) |
|
|
(3,011 |
) |
Purchase
of marketable securities |
|
(19,322 |
) |
|
|
(32,299 |
) |
Proceeds
from the sale of marketable securities |
|
10,268 |
|
|
|
16,524 |
|
Capital
expenditures |
|
(1,686 |
) |
|
|
(2,254 |
) |
Net cash used in investing activities |
|
(10,774 |
) |
|
|
(21,040 |
) |
Cash flows from
financing activities |
|
|
|
Minimum
tax withholding on stock options exercised and awards vested |
|
(8 |
) |
|
|
(55 |
) |
Excess
tax benefits associated with stock options and awards |
|
(1 |
) |
|
|
(136 |
) |
Payment
of dividends |
|
(105,438 |
) |
|
|
(5,246 |
) |
Net cash used in financing activities |
|
(105,447 |
) |
|
|
(5,437 |
) |
Net change in cash and
cash equivalents |
|
(88,262 |
) |
|
|
19,551 |
|
Cash and cash
equivalents at beginning of period |
|
199,272 |
|
|
|
154,049 |
|
Cash and cash
equivalents at end of period |
$ |
111,010 |
|
|
$ |
173,600 |
|
|
|
|
|
Cash paid for
interest |
$ |
- |
|
|
$ |
- |
|
Cash paid for income
taxes |
$ |
55 |
|
|
$ |
985 |
|
FutureFuel Corp. |
Reconciliation of Non-GAAP Financial Measure
to Financial Measure |
(Dollars in thousands) |
(Unaudited) |
|
Reconciliation of Adjusted EBITDA to Net
Income |
|
|
Three months ended June 30, |
|
Six months ended June 30, |
|
|
2017 |
|
|
2016(1) |
|
|
2017 |
|
|
2016(1) |
Adjusted EBITDA |
$ |
2,079 |
|
|
$ |
13,581 |
|
|
$ |
7,648 |
|
|
$ |
26,283 |
|
Depreciation |
|
(2,912 |
) |
|
|
(2,671 |
) |
|
|
(5,808 |
) |
|
|
(5,329 |
) |
Non-cash stock-based
compensation |
|
(273 |
) |
|
|
(477 |
) |
|
|
(750 |
) |
|
|
(954 |
) |
Interest and dividend
income |
|
1,991 |
|
|
|
1,464 |
|
|
|
3,714 |
|
|
|
2,809 |
|
Interest expense |
|
(43 |
) |
|
|
(42 |
) |
|
|
(86 |
) |
|
|
(85 |
) |
Losses on disposal of
property and equipment |
|
(46 |
) |
|
|
(22 |
) |
|
|
(77 |
) |
|
|
(137 |
) |
Gains/(losses) on
derivative instruments |
|
524 |
|
|
|
(5,139 |
) |
|
|
1,803 |
|
|
|
(6,178 |
) |
Gains/(losses) on
marketable securities |
|
(438 |
) |
|
|
613 |
|
|
|
(569 |
) |
|
|
(405 |
) |
Income tax
(expense)/benefit |
|
(48 |
) |
|
|
6,917 |
|
|
|
(1,645 |
) |
|
|
8,789 |
|
Net income |
$ |
834 |
|
|
$ |
14,224 |
|
|
$ |
4,230 |
|
|
$ |
24,793 |
|
Reconciliation of Adjusted EBITDA to Net Cash Provided by
Operating Activities |
|
|
Six months ended June 30, |
|
|
2017 |
|
|
2016(1) |
Adjusted EBITDA |
$ |
7,648 |
|
|
$ |
26,283 |
|
Provision for deferred
income taxes |
|
(1,763 |
) |
|
|
(4,969 |
) |
Impairment of fixed
assets |
|
9 |
|
|
|
178 |
|
Interest and dividend
income |
|
3,714 |
|
|
|
2,809 |
|
Income tax
(expense)/benefit |
|
(1,645 |
) |
|
|
8,789 |
|
Gains/(losses) on
derivative instruments |
|
1,803 |
|
|
|
(6,178 |
) |
Change in fair value of
derivative instruments |
|
318 |
|
|
|
4,869 |
|
Changes in operating
assets and liabilities, net |
|
17,876 |
|
|
|
14,310 |
|
Other |
|
(1 |
) |
|
|
(63 |
) |
Net cash provided by
operating activities |
$ |
27,959 |
|
|
$ |
46,028 |
|
|
(1)
Prior year adjusted EBITDA reconciliations have been modified
to be consistent with current year presentations. |
|
FutureFuel Corp. |
Condensed Consolidated Segment
Income |
(Dollars in thousands) |
(Unaudited) |
|
|
Three months ended June 30, |
|
Six months ended June 30, |
|
|
2017 |
|
|
|
2016 |
|
|
|
2017 |
|
|
|
2016 |
|
Revenue |
|
|
|
|
|
|
|
Custom
chemicals |
$ |
19,644 |
|
|
$ |
19,401 |
|
|
$ |
41,596 |
|
|
$ |
39,693 |
|
Performance chemicals |
|
3,707 |
|
|
|
5,162 |
|
|
|
8,112 |
|
|
|
9,938 |
|
Chemicals
revenue |
$ |
23,351 |
|
|
$ |
24,563 |
|
|
$ |
49,708 |
|
|
$ |
49,631 |
|
Biofuels
revenue |
|
44,697 |
|
|
|
43,316 |
|
|
|
72,451 |
|
|
|
64,883 |
|
Total Revenue |
$ |
68,048 |
|
|
$ |
67,879 |
|
|
$ |
122,159 |
|
|
$ |
114,514 |
|
|
|
|
|
|
|
|
|
Segment gross
profit |
|
|
|
|
|
|
|
Chemicals |
$ |
5,332 |
|
|
$ |
6,297 |
|
|
$ |
12,341 |
|
|
$ |
14,869 |
|
Biofuels |
|
(3,534 |
) |
|
|
1,675 |
|
|
|
(4,413 |
) |
|
|
4,156 |
|
Total gross profit |
|
1,798 |
|
|
|
7,972 |
|
|
|
7,928 |
|
|
|
19,025 |
|
Corporate expenses |
|
(2,424 |
) |
|
|
(2,596 |
) |
|
|
(5,079 |
) |
|
|
(5,120 |
) |
Income/(loss) before
interest and taxes |
|
(626 |
) |
|
|
5,376 |
|
|
|
2,849 |
|
|
|
13,905 |
|
Interest and other
income |
|
1,991 |
|
|
|
1,464 |
|
|
|
3,714 |
|
|
|
2,809 |
|
Interest and other
expense |
|
(483 |
) |
|
|
467 |
|
|
|
(688 |
) |
|
|
(710 |
) |
(Provision)/benefit for
income taxes |
|
(48 |
) |
|
|
6,917 |
|
|
|
(1,645 |
) |
|
|
8,789 |
|
Net income |
$ |
834 |
|
|
$ |
14,224 |
|
|
$ |
4,230 |
|
|
$ |
24,793 |
|
|
Depreciation is allocated to segment costs of goods
sold based on plant usage. The total assets and capital
expenditures of FutureFuel have not been allocated to individual
segments as large portions of these assets are shared to varying
degrees by each segment, causing such an allocation to be of little
value.
COMPANY CONTACT
FutureFuel Corp.
Tom McKinlay
(314) 854-8352
www.futurefuelcorporation.com
FutureFuel (NYSE:FF)
Historical Stock Chart
From Mar 2024 to Apr 2024
FutureFuel (NYSE:FF)
Historical Stock Chart
From Apr 2023 to Apr 2024